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Abstract 
Manganese in its divalent state (Mn2+) has features that make it a unique tool for tracing neuronal 
pathways. It is taken up and transported by neurons in an activity dependent manner and it can 
cross synapses. It also acts as a contrast agent for magnetic resonance imaging (MRI) enabling 
visualization of neuronal tracts. However, due to the limited sensitivity of MRI systems relatively 
high Mn2+ doses are required. This is undesirable, especially in long-term studies, because of the 
known toxicity of the metal. 
In order to overcome this limitation, we propose 52Mn as a positron emission tomography (PET) 
neuronal tract tracer. We used 52Mn for imaging dopaminergic pathways after a unilateral 
injection into the ventral tegmental area (VTA), as well as the striatonigral pathway after an 
injection into the dorsal striatum (STR) in rats. Furthermore, we tested potentially noxious effects 
of the radioactivity dose with a behavioral test and histological staining. 
24 h after 52Mn administration, the neuronal tracts were clearly visible in PET images and 
statistical analysis confirmed the observed distribution of the tracer. We noticed a behavioral 
impairment in some animals treated with 170 kBq of 52Mn, most likely caused by dysfunction of 
dopaminergic cells. Moreover, there was a substantial DNA damage in the brain tissue after 
applying 150 kBq of the tracer. However, all those effects were completely eliminated by 
reducing the 52Mn dose to 20-30 kBq. Crucially, the reduced dose was still sufficient for PET 
imaging. 
 
Key words: 52Mn, manganese toxicity, neuronal pathways, PET, γH2AX, rat. 
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Abbreviations 
AMG – amygdala 
CER – cerebellum  
γH2AX – γ-phosphorylated histone protein H2AX  
GP – globus pallidus 
TH – tyrosine hydroxylase 
NA – nucleus accumbens 
OT – olfactory tubercle 
PFC – prefrontal cortex 
SN – substantia nigra 
STR – striatum 
THL – thalamus 
VTA – ventral tegmental area 
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1 Introduction 
Divalent manganese (Mn2+) has properties that make it a unique tool for in vivo imaging of 
neuronal pathways. Being a paramagnetic substance, it reduces the spin-lattice relaxation time 
(T1) of surrounding water protons and, therefore, acts as a contrast agent in T1-weighted 
magnetic resonance (MR) images (Pautler et al., 1998, Saleem et al., 2002). When administered 
to the neural tissue, Mn2+ enters neurons via different types of ion channels, including voltage-
gated calcium channels (Drapeau and Nachshen, 1984, Narita et al., 1990, Crossgrove and Yokel, 
2005), as well as metal transporters, including divalent metal transporter 1 (DMT1) (Garrick et 
al., 2003, Au et al., 2008). Most importantly for neuroscientific studies, Mn2+ is further 
transported by neural cells and can cross synapses (Sloot and Gramsbergen, 1994, Pautler et al., 
1998, Saleem et al., 2002), which is not the case for all divalent metal ions (Tjalve et al., 1996). 
Moreover, this neuronal transport is, at least partially, activity-dependent which enables 
functional imaging of brain connectivity (Van der Linden et al., 2004, Bearer et al., 2007, Yang 
et al., 2011, Wang et al., 2015). Due to these unique characteristics, manganese – enhanced MRI 
(MEMRI) has been widely used for anatomical measurements, as well as investigations of 
neuronal function and plasticity in rodents, birds, and primates (Saleem et al., 2002, Van der 
Linden et al., 2004, Watanabe et al., 2004, Canals et al., 2008, Doron and Goelman, 2010, Zhang 
et al., 2010). 
Currently, two other MRI techniques are also commonly used for in vivo functional imaging of 
brain connectivity in experimental animals: blood oxygenation level dependent (BOLD) fMRI 
and diffusion tensor imaging (DTI). Both methods allow multiple measurements in the same 
animal and, therefore, longitudinal investigation of developmental changes or modifications of 
the brain network related to the experimental treatment. However, fMRI as well as DTI 
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experiments require either anesthetizing or physical restraining of the animal. This is a serious 
limitation for any investigation which aims at correlating neuronal activity with behavior. 
Although some studies involving sensory responses, or even classical conditioning paradigms, 
have been performed in mice and rats using BOLD fMRI (Harris et al., 2015, Schlegel et al., 
2015), many other well established classical and instrumental learning paradigms cannot be used. 
Particularly in rodents, the most common experimental animals, an actively expressed behavior, 
for instance pressing a lever or exploring a new territory, is a measure of brain function. 
Obviously, those cannot be used in anesthetized or immobilized animals. 
In contrast, in MEMRI studies anesthesia and restraining do not need to be used while the animal 
is performing the task. Mn2+ can be administered to the brain of an awake rat via a cannula that 
had been previously fixed on the skull. Subsequently, the animal undergoes the behavioral test 
while Mn2+ spreads to the involved brain regions. MRI acquisition takes place afterwards to read 
out the Mn2+ distribution (Inui et al., 2011). This approach is unique among the available MRI 
techniques. 
However, manganese toxicity, which mainly affects the central nervous system, is a limitation of 
MEMRI, especially in repetitive studies. It has been long recognized that prolonged exposure to 
manganese leads to a disease called manganism (Barbeau, 1983). The basal ganglia, and the 
dopaminergic neurons in particular, are most vulnerable to manganese (Eriksson et al., 1992, 
Stanwood et al., 2009, Sriram et al., 2010). As a result, motor extrapyramidal symptoms, 
resembling those of Parkinson’s disease patients, are a common manifestation in humans (Huang 
et al., 1998, Tuschl et al., 2013) as well as in experimental animals (Eriksson et al., 1987, Olanow 
et al., 1996). Consequently, Mn2+ doses used in MEMRI studies must be carefully evaluated, 
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especially in studies focusing on the dopaminergic pathways and involving instrumental 
behavior. 
Currently, doses in the range of tens of nmol are typically used for tracing neuronal pathways 
with MEMRI (Saleem et al., 2002, Murayama et al., 2006, Li et al., 2009). However, it has been 
shown that 50 nmol of Mn2+ injected into the vitreous body of a mouse eye disturbed neuronal 
electrophysiology measured in the visual cortex (Bearer et al., 2007). A similar dose (45 nmol of 
Mn2+) caused degeneration of the dopaminergic ventral tegmental area (VTA) neurons after a 
direct intracerebral injection in rats (own unpublished data). In another study, 40 nmol of Mn2+ 
unilaterally injected into a rat VTA was found to significantly affect the cells morphology, and 
even the 20 nmol dose reduced the number of “normal-appearing neurons” (Li et al., 2009).  
A dose lower than 10 nmol has been applied and reported not to cause toxicity (Canals et al., 
2008). However, that study focused on cortical and not midbrain neurons. Furthermore, a signal 
change measured 24 h after an injection of only a few nmol of Mn2+ was not detectable by an 
11 T MR scanner (Bearer et al., 2007). Therefore, when doses below 10 nmol are used the MR 
acquisition either takes place directly after the injection (Canals et al., 2008) or requires a 
scanning time of several hours (Pautler et al., 2003). 
Thus, even though the usefulness of Mn2+ has been well established, the sensitivity of MRI 
systems is a limiting factor, especially for longitudinal studies or when the brain circuits 
containing dopaminergic neurons are of interest. In order to overcome this limitation we propose 
an imaging technique alternative to MEMRI, namely using 52gMn (T½ = 5.6 days, β+ = 29.4 % (Le 
Loirec and Champion, 2007), from here on referred to as 52Mn ) as a PET neuronal tract tracer. 
The radionuclide has a favorably low mean and maximum positron energies of 244.6 keV and 
576 keV, respectively (Le Loirec and Champion, 2007). Positron energy determines positron 
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range which in turn has a strong impact on the quality of PET images. In fact, the mean range in 
the tissue for 52Mn protons is 0.63 mm, which is very close to the mean positron range of 18F 
(0.62 mm), a commonly used PET isotope (Topping et al., 2013). Consequently, similar image 
quality can be expected. 
Furthermore, 52Mn production and separation methods have been recently developed and 
optimized (Lahiri et al., 2006, Buchholz et al., 2013, Buchholz et al., 2015, Graves et al., 2015, 
Fonslet et al., 2017) and the tracer has been just introduced into the field of preclinical imaging 
(Topping et al., 2013, Graves et al., 2015, Lewis et al., 2015). The biggest advantage of using 
52Mn for tracing neuronal pathways would lie in the possibility to reduce the manganese dose to 
the pico-molar range which should eliminate the toxic effects and allow multiple administrations. 
In the present work we investigated whether 52Mn could be used for tracing neuronal pathways 
with PET. Our goal was to visualize the distribution of the tracer in the rat brain 24 h after a 
direct intracerebral administration. Based on the known properties of Mn2+, we expected 52Mn to 
follow neuronal tracts. Moreover, we aimed to assess a potentially harmful impact of the tracer 
on dopaminergic neurons. Hence, we employed a behavioral test which can reveal an impairment 
of the motor control system, as well as a specific immunohistochemical staining. We also 
evaluated the impact of different radioactivity doses on the DNA damage in the VTA.  
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2 Materials and Methods 
2.1 Study Design 
Phantom Measurement: A resolution phantom was filled with 52Mn solution and PET was 
performed. The image was reconstructed using different algorithms and matrix sizes in order to 
evaluate the quality that can be achieved with 52Mn PET imaging. 
Experiment 1: 4 rats were injected with 52Mn solution into the right VTA (VTA group) and 4 into 
the right dorsal striatum (STR group). The injected radioactivity dose was 169 ± 24 kBq (further 
denoted as 170 kBq). Approximately 3 months later, another 4 rats were injected into the right 
VTA with the same solution which by that time had decayed (VTA decayed group). The first two 
groups underwent PET and MRI 24 h after the injection and all 12 animals underwent the 
rotameter test 4 weeks post-injection. 1 day after the behavioural test they were sacrificed and the 
brains were used for tyrosine hydroxylase (TH-) staining. 
Experiment 2: The outcome of Experiment 1 suggested that the applied radioactivity dose had 
induced a lesion of dopaminergic neurons. In order to better understand this effect, we 
investigated the impact of 52Mn on the DNA of the cells at the injection site. 
4 rats were injected into the VTA with 149 ± 10 kBq (further denoted as 150 kBq) and 4 with 
28 ± 6 kBq (further referred to as 30 kBq) of 52Mn. Another 4 rats served as a control group and 
were treated with 0.9% NaCl solution. 2 rats from each group were sacrificed at 90 min and 2 at 
24 h post-injection. The brains were used for the immunohistochemical staining against 
γ-phosphorylated histone protein H2AX (γH2AX-staining). 
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Experiment 3: Based on the results of Experiments 1 and 2, we expected that reduction of the 
radioactivity dose should prevent dopaminergic lesion. Additionally, we aimed to improve the 
purity of the 52Mn solution and, therefore, a different separation method was used to prepare the 
tracer for Experiment 3 (please, see the Radiochemistry section for details). 
18 rats were injected with the reduced dose of 52Mn (20 ± 5 kBq) into the right VTA. 6 control 
rats were injected into the same brain region but with 0.9% NaCl solution containing 10 mM Na 
ascorbate (a buffer of the 52Mn solution). PET and MRI were performed 24 h later. The 52Mn-
injected rats underwent the rotameter test at 3, 14, or 28 days post-injection (n = 6 per group) and 
the control rats at 28 days post-injection. 1 day after the behavioural test the animals were 
sacrificed and the brains were removed. 3 brains from each group were dedicated for the 
TH-staining. 
2.2 Radiochemistry  
52Mn was produced by proton irradiation of unenriched chromium (Cr) metal. Following 
irradiation the produced 52Mn was separated from the Cr matrix by solvent extraction into 
trioctylamine followed by anion exchange purification, a procedure adapted from Lahiri et al 
(Lahiri et al., 2006) – used in Experiment 1, or by three sequential anion exchange purifications, 
an adaptation from the procedure of Graves et al (Graves et al., 2015) – used in Experiment 3. 
The two methods resulted in different specific activities and metal contents, as discussed in the 
Results section. For a detailed description of the radiochemical separations, please, see the 
Supplementary Data file. 
The purified 52Mn was reconstituted for injection with 10 mM Na (L+) ascorbate in normal 
saline. It was in a form of a divalent ion and, therefore, a more precise abbreviation would be 
“
52Mn2+”. However, for the sake of simplicity, “52Mn” is used throughout this work. 
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Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES) (Thermo Scientific iCAP 
6000 Series, Thermo Fischer Scientific, Waltham, MA, USA) was used to measure the 
concentration of metal contaminants versus Ag, Cr, Ni, Cu, Fe, Mn, Ca and Zn standards. 
2.3 Phantom Measurement 
An Ultra-Micro Hot Spot Phantom (Data Spectrum Corporation, Durham, NC, USA) made of 
polymethyl methacrylate was used. It contains a fillable cylindrical volume connected with six 
sets of rods with the following diameters: 0.75 mm, 1.00 mm, 1.35 mm, 1.70 mm, 2.00 mm, and 
2.40 mm, as depicted in Supplementary Figure 1.  
The phantom was filled with 52Mn solution (2.9 MBq in 6 mL) and positioned in the center of the 
field of view (FOV) of a µPET scanner (Inveon dedicated PET, Siemens Healthineers, Knoxville, 
TN, USA). PET acquisition was performed over 20 min, which was followed by a 10 min 
transmission scan, using Inveon Acquisition Workplace (v.1.5.0.28, Siemens). The decay, dead 
time, and attenuation corrections, as well as normalization, were applied. The image was 
reconstructed using: filtered back-projection (FBP) algorithm and the matrix size of 128 × 128 
(i), ordered subset expectation maximization (OSEM) 2D algorithm and the matrix size of 128 × 
128 (ii), OSEM3D-maximum a posteriori (MAP) algorithm and the matrix size of 128 × 128 (iii), 
and the OSEM3D-MAP algorithm but the 256 × 256 matrix size (iv). The obtained images were 
visually compared. 
2.4 Animals 
All procedures followed the guidelines and international standards of the care and use 
of laboratory animals and were approved by the local Animal Welfare and Ethics Committee 
of the Country Commission Tübingen, Germany (Animal License No R5/13). A total of 48 Lister 
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Hooded male rats were used in this study. They were housed in IVCs in groups of 4 with food 
and tap water access ad libitum, and were kept on a 12:12 h light:dark cycle and 22 ± 1°C. 
2.5 Stereotactic Injection 
The rats were anesthetized intraperitoneally (i.p.) with the medetomidine / midazolam / fentanyl 
mixture (0.15 / 2.0 / 0.005 mg/kg b. w.). They were placed in a stereotactic frame equipped with 
a heating mat and the head was fixed with ear and tooth bars. The skull surface was exposed and 
a small hole was drilled -2.0 mm lateral and -5.2 mm posterior to Bregma to aim at the VTA, or -
3.2 mm lateral and 0.7 mm anterior to Bregma for the STR injection (Paxinos and Watson, 2007). 
A 26 G needle was attached to a 5 µL Hamilton syringe and inserted with an angle of 8° reaching 
-8.0 mm from the skull surface for the VTA injection, or with 0° angle and reaching -5.1 mm for 
the STR injection. 1 µL (Experiment 1) or 1.5 µL (Experiments 2 and 3) of the solution was 
injected using an infusion pump at the rate of 0.25 µL/min. The needle was left in position for the 
following 5-6 min. After a slow withdrawal of the needle, the hole in the skull was sealed with 
wax and the skin was sewn. The radioactivity in the syringe was measured in a well counter 
before and after the injection.  
2.6 In Vivo PET and MRI Measurements 
The isoflurane-oxygen mixture was used for anesthesia (2.5 % isoflurane for induction and 1.7 % 
for maintenance) and body temperature was kept at 37 ± 0.5 °C. In order to register the PET and 
MR images a thin tube, filled with a diluted 52Mn solution, was put around the neck of each rat. 
The head was fixed and the animal was transferred from the PET to the MRI scanner on the same 
bed. 
Static PET measurements were performed on the same PET scanner and with the same 
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acquisition software as the phantom measurement. The acquisition started 24 ± 0.5 h after the 
tracer injection, lasted 20 min (Experiment 1) or 60 min (Experiment 3), and was followed by a 
10 min transmission scan performed with a rotating 57Co source. The decay, dead time, and 
attenuation corrections, as well as normalization, were applied to the PET data. The images were 
reconstructed with the OSEM3D-MAP algorithm and the matrix size of 256 × 256 × 159. 
MRI was performed directly after PET on a 7 T small animal MR scanner (ClinScan, Bruker 
BioSpin, Ettlingen, Germany) equipped with a rat brain coil (Bruker BioSpin). Image acquisition 
was performed with Syngo MRI software (Siemens Medical Solutions, Erlangen, Germany). T2-
weighted (T2W) images were obtained using the following parameters: TR = 3000 ms, TE = 205 
ms, FOVr = 57 mm, FOVph = 35.625 mm, slice thickness = 0.22 mm, and the matrix size was 256 
× 256. 
2.7 PET and MR Image Analysis 
PET and MR image analysis was performed with Pmod software v.3.2. (PMOD Technologies 
LCC, Zürich, Switzerland). The T2W MR images were registered to the anatomical template and 
subsequently, each PET image was registered to its corresponding T2W image. Volumes of 
interest (VOIs) were drawn on the template in the coronal plane according to the rat brain atlas 
(Paxinos and Watson, 2007). They included: nucleus accumbens (NAC), olfactory tubercle (OT), 
amygdala (AMG), striatum (STR), prefrontal cortex (PFC), globus pallidus (GP), thalamus 
(THL), substantia nigra (SN), and cerebellum (CER). The last one served as a control region. The 
VOIs were subsequently copied onto the registered PET images and the average activity of each 
VOI was used for quantification. The VOIs are depicted in Figure 1. 
Statistical analysis was performed on the PET data from Experiment 3 using the average signal 
from each ipsilateral and contralateral VOI. In order to achieve normal distribution (verified with 
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Shapiro-Wilk test) and homogeneity of variances (verified with Levene’s test) all the data were 
log-transformed. A mixed design ANOVA assuming “brain side” (ipsilateral or contralateral) as 
a between-subjects factor and “region” as a within-subjects factor was performed using SPSS 
Statistics 2.2 (IBM Corporation, Armonk, NY, USA). The assumption of sphericity was verified 
with Mauchly’s test. The omnibus test was followed by Tukey’s post-hoc test. The results were 
considered significant for p ≤ 0.05. 
2.8 Rotameter Test 
The test was based on the original study by Ungerstedt and Arbuthnott  (Ungerstedt and 
Arbuthnott, 1970) and performed with a set of 4 concave hemi-spheres (“bowls”) connected to an 
automated rotameter system (TSE Systems GmBH, Bad Homburg, Germany). The system counts 
a difference in the animal location of 30°, thus, each 1/12th of a full rotation is registered.  
During the test each rat wore a collar connected to the measuring system by a wire. Its length was 
adjusted to allow the animal to reach the edge of the bowl but not to go beyond it. The number of 
rotations the rat performed clockwise and counterclockwise was recorded over 10 min (baseline). 
Then, recording was paused for 1-2 min in order to apply an apomorphine injection 
(apomorphine hydrochloride, Sigma Aldrich, Hamburg, Germany, 0.25 mg/kg b.w., s.c.) and 
subsequently run again for 30 min. The first 10 min after the injection were considered the uptake 
time (Dunnett, 2011) and excluded from the analysis. The rotations recorded during the 
remaining 20 min were divided into two 10 min bins and averaged (test). The results are 
expressed as a ratio of the number of ipsilateral over contralateral rotations per 10 min (further 
referred to as “ipsilateral/contralateral rotations”).  
In Experiment 1 the individual scores of the rats at the baseline measurement were compared to 
their scores at the test measurement which is presented graphically. The results of Experiment 3 
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were analyzed statistically by a mixed-design ANOVA in which the “group” (3 days, 14 days, 
28 days, or 28 days-control) was considered a between-subjects factor and the “measurement” 
(baseline or test) a within-subjects factor. The assumptions of normal distribution and 
homogeneity of variances were tested as for the PET data analysis. The tests were performed 
with SPSS Statistics 2.2 software (IBM Corporation) and the results were considered significant 
for p ≤ 0.05.  
2.9 TH-Staining 
The dissected brains were kept 24 h in 4 % paraformaldehyde solution (PFA) at 4 °C and, 
subsequently, in 30 % glucose solution at 4 °C for at least 3 days. Afterwards, they were 
embedded in TissueTek (Sakura, Zoeterwonde, The Netherlands) and stored at -20 °C. 20 µm 
sections were obtained from each brain in coronal plane with a cryotome (Leica Biosystems, 
Wetzlar, Germany). In case of the VTA-injected brains, the sections were taken at the injection 
level which could be easily identified by a small hole that remained on the cortex surface. From 
the STR-injected brains, the sections were taken at the level of substantia nigra, which could be 
recognized during cutting based on the anatomical features. 
The following substances were used for the TH-staining: a primary monoclonal TH antibody 
(ImmunoStar, Inc., Hudson, US, ), a biotinylated anti-mouse IgG antibody (Vector Laboratories 
Ltd., Peterborough, UK), 3,3'-diaminobenzidine (DAB Substrate Kit, Vector Laboratories Ltd.), 
and an immunoperoxidase system (Vectastain Elite ABC-Kit, Vector Laboratories Ltd.). 
According to the manufacturers’ instructions, the antibodies were used at the dilution of 1/1000. 
The stained tissues were scanned with NanoZoomer 2.0HT (Hamamatsu Photonics K.K., 
Hamamatsu, Japan) and the scans obtained at the magnification of 2.5 were saved as .tif files. 
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These images were further analyzed with ImageJ 2.0.0 software (U. S. National Institutes of 
Health, Bethesda, Maryland, USA). 
Firstly, the scan was converted into an 8 bit grey scale image. Therefore, the signal intensity 
values were normalized to the 0-255 range. This was subsequently inverted in order to associate 
dark staining with high pixel values. Finally, circular regions of interest (ROIs), with the area of 
approximately 0.1 mm 2, were drawn on the inverted image: one ROI on each VTA (or on each 
SN in the STR group) and one ROI above each VTA (or SN) to measure the corresponding 
background value. The described steps of the image analysis are depicted in the Supplementary 
Figure 2. 
The mean value of each background ROI was subtracted from the mean value of its 
corresponding VTA ROI. The results of the subtraction were used as the measure of the staining 
intensity of the injected and the non-injected VTA (or of the ipsilateral and the contralateral SN 
regions in the STR group). For each experimental group, the staining intensities were statistically 
compared to each other using the paired t-test. The results between the right and the left side were 
considered significant for p ≤ 0.05. 
2.10 γH2AX-Staining 
The dissected brains were kept in 4% PFA at 4 °C for 24 h, dehydrated in ethanol solutions of 
increasing concentration, and embedded in paraffin. From each brain, a 3 µm section was cut in 
coronal plane at the level of the injection. The sections were dried on glass slides at 37 °C for 
48 h. Preparation for the staining involved: deparafinization (xylene), rehydration (ethanol 
solutions of decreasing concentration), washing (PBS), epitope retrieval (microwaving in citrate 
buffer), cooling (ice), and final washing (PBS). The anti-phospho-histone H2AX (Ser139) clone 
JBW301 antibody (Merck Millipore, Darmstadt, Germany) and Tyramide Signal Amplification 
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Kit (TSA, Alexa Fluor 488, Life Technologies GmbH, Darmstadt, Germany) were used 
according to the manufacturer’s instructions. This included the dilutions of 1/1000 for the 
antibody, and 1/100 for TSA. 
All sections were counterstained with 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) 
(Sigma Aldrich).  
A Zeiss Axio Imager MI fluorescence microscope, equipped with a monochrome digital camera 
(AxioCam MRm) and controlled by AxioVision 4.8 software (Carl Zeiss, Jena, Germany), was 
used for evaluation of γH2AX foci. For each brain section (1 section per animal) three adjacent 
“stack-images” were taken from the injected VTA region and three from the contralateral VTA. 
Every stack-image was obtained by merging seven 2D layers (230 µm × 170 µm) acquired in 
different microscopic focus planes in the direction of z axis, with 0.25 µm distance in between 
them. This is depicted in Supplementary Figure 3. 
The analysis of the stack-images relied on counting the nuclei that contained at least 3 foci 
(further referred to as “cells with foci”) as well as the total number of nuclei in the image (“cells 
total”). The nuclei at the edges of the image were not included. For every stack-image the “cells 
with foci/cells total” ratio was calculated. The results from the three ipsilateral stack-images were 
averaged as well as the results from the three contralateral stack-images. Therefore, one number 
for the ipsilateral VTA and one number for the contralateral VTA were obtained for each rat. 
Those were used to calculate group means and standard deviations which are presented 
graphically. 
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3 Results 
3.1 Phantom Measurement 
The images of the phantom obtained with different reconstruction algorithms and matrix sizes are 
shown in Figure 2. 
The rod volumes of the 0.75 mm and 1.00 mm diameters could not be resolved by any of the 
algorithms. However, the 1.35 mm diameter rods could be distinguished in the images 
reconstructed with the OSEM3D-MAP algorithm. Moreover, the edges of these rods appeared 
sharper and the spaces between them clearer, when the 256 × 256 matrix size was applied. 
Because some of the brain regions to be imaged in rats have the dimensions as small as 1-2 mm 
(e.g. substantia nigra), the OSEM3D-MAP algorithm and the 256 × 256 matrix size were used for 
reconstructing all the in vivo PET data. 
3.2 Tracing neuronal pathways with 52Mn PET: Impact of 170 kBq on the dopaminergic 
system (Experiment 1) 
3.2.1 Metal Content in the Tracer Solution 
ICP-OES measurements of the 52Mn solution used in Experiment 1 revealed that the injection 
volume (1 µL) contained: 2.1 ng (38.3 pmol) of Mn, 0.9 ng (16.9 pmol) of Fe, and < 0.2 ng 
(< 3.8 pmol) of Cr. No other metal contaminants were detected. The specific activity (SA) at the 
injection times was 3.18-3.30 GBq/µmol. 
3.2.2 PET Measurements 
24 h after 52Mn injection into the VTA, known dopaminergic pathways could be identified in all 
PET images. The tracer was clearly delineated along the mesolimbic as well as the nigrostriatal 
tracts (Fig. 3A). Among the analyzed regions, the highest content of 52Mn was found in the 
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ipsilateral NAC (0.25 ± 0.04 %ID/mm3), STR (0.18 ± 0.05 %ID/mm3), and OT (0.12 ± 0.02 
%ID/mm3). The AMG and the PFC accumulated lower doses (0.05 ± 0.01 and 0.04 ± 0.01 
%ID/mm3, respectively). For all the analyzed regions the tracer content on the contralateral side 
was lower than on the ipsilateral side, and only the right and left CER contained the same, very 
little, amount of 52Mn (0.02 %ID/mm3) (Fig. 4A). 
In all the images of the rats injected into the STR, the striatonigral pathway was clearly 
delineated by 52Mn (Fig. 3B). The tracer accumulation in the ipsilateral VOIs was as follows: 
1.16 ± 0.14 %ID/mm3 in the GP, 0.31 ± 0.05 %ID/mm3 in the THL, and 0.14 ± 0.06 %ID/mm3 in 
the SN. Similarly to the VTA group, 52Mn content in all the contralateral areas, as well as on both 
sides of the CER, was in the range of 0.01 – 0.02 %ID/mm3 (Fig. 4B). 
3.2.3 Rotameter Test 
During the baseline measurement, all the animals rotated approximately equally to the ipsilateral 
and contralateral directions yielding the average “ipsilateral/contralateral rotations” of 0.9 ± 0.1 
in the VTA group, 1.0 ± 0.2 in the STR group, and 1.2 ± 0.2 in the VTA decayed group. However, 
the average values in the VTA and S R groups raised to 2.4 ± 2.3 and 2.4 ± 2.6, respectively, 
following the apomorphine stimulation. The test result of the VTA decayed group remained 
similar to the baseline, 1.0 ± 0.2 (Suppl. Fig. 4D). The high SD of the VTA and STR test results 
were caused by 4 rats (No 1, 2, 6 and 8) which rotated at least two times more to the ipsilateral 
than contralateral direction, suggesting an imbalance of the motor control system. No animal 
from the VTA decayed group showed this effect (Suppl. Fig. 4A-C). 
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3.2.4 TH-Staining 
In the VTA group, we observed reduced staining intensity at the injection site compared to the 
contralateral VTA (Fig. 5A) which indicated a dopaminergic lesion. This was also reflected in the 
semi-quantitative results. The intensity in the right VTA was 72 ± 9 (group mean ± sd) and it was 
significantly lower than the 94 ± 16 measured in the left VTA (Fig. 6A). 
The difference between the right and the left SN of the intrastriatally injected rats was clearly 
visible in only one animal (Fig. 5B). This was reflected in the semi-quantification of the results 
which did not show a significant difference but were characterized by the relatively high standard 
deviation. The staining intensity in the ipsilateral SN was 52 ± 26 (group mean ± sd) and it was 
57 ± 16 for the contralateral SN (Fig. 6B).  
Finally, there was no difference between the injected and the non-injected VTAs in the group 
treated with the decayed solution (Fig. 5C and Fig. 6C). 
3.3 Impact of 150 kBq and 30 kBq of 52Mn on DNA Strand Breaks in the VTA 
(Experiment 2) 
In order to better understand the noxious effects observed in some animals in Experiment 1, we 
injected additional rats with high (149 ± 10 kBq, for simplicity called “150 kBq”) or low (28 ± 
6 kBq, called “30 kBq”) dose of 52Mn into the right VTA. The control group was treated with 
saline and all the brain tissues were stained for the γ-phosphorylated histone protein H2AX. 
In the controls sacrificed 90 min post-injection, only a few and mostly very small foci were 
present in the injected as well as the non-injected VTA (Fig. 7A-B). At this time point, the foci 
appearance and distribution in the tissues treated with the low radioactivity dose were similar 
(Fig. 7C-D). In contrast, we found multiple, and often clustered, foci at the injection location of 
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the high dose-treated brain tissues. The foci in the contralateral VTA in this group were clearly 
smaller and less numerous, although they still appeared more frequent than in the low dose and 
control groups (Fig. 7E-F).  
Semi-quantification of the images confirmed the qualitative result. It revealed that in the injected 
VTA, the fraction of cells containing at least 3 foci was approximately 8 times higher in the 
150 kBq group (0.26 ± 0.03) compared to the 0 kBq and 30 kBq groups (0.03 ± 0.02 and 0.02 ± 
0.03, respectively). This fraction on the contralateral side in the high-dose group was 0.09 ± 0.05, 
which was still 4 times higher than in the low dose (0.02 ± 0.02) and control (0.02 ± 0.03) groups 
(Fig. 8). 
Contrary to the strong effect found at the early time point, the “cells with foci/cells total” ratios 
were more uniform across the three groups at the 24 h time point. Nevertheless, the fraction of 
cells with at least 3 foci was still 0.11 ± 0.06 in the VTA injected with 150 kBq, while it was only 
0.06 ± 0.01 in the control group and 0.03 ± 0.02 in the 30 kBq group. The corresponding 
contralateral values were as follows: 0.06 ± 0.02 for the 150 kBq group, 0.02 ± 0.02 for the 
30 kBq group, and 0.05 ± 0.06 for the controls (Suppl. Fig. 5). These results reflected the 
qualitative evaluation of the images (Suppl. Fig. 4). 
3.4 Tracing neuronal pathways with 52Mn PET: Impact of 20 kBq on the 
dopaminergic system (Experiment 3) 
3.4.1 Metal Content 
ICP-OES measurements of the solution used in Experiment 3 showed that each 1.5 µL dose 
contained: 0.1 ng (1.6 pmol) of Mn, and < 0.14 ng (< 2.7 pmol) of Cr. No other metal 
contaminants were detected. The SA at the injection times was: 21.3-23.8 GBq/µmol. 
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3.4.2 PET Measurements 
Despite the reduced dose of 52Mn, the tracer distribution pattern at 24 h post-injection was similar 
to the one observed in Experiment 1. The mesolimbic and nigrostriatal pathways could be again 
recognized in the PET images (Fig. 9). Among the analyzed regions, the ipsilateral NAC once 
again contained the highest amount of the tracer, 0.17 ± 0.05 %ID/mm3. The contents in the STR 
and OT were 0.10 ± 0.03 and 0.11 ± 0.04 %ID/mm3, respectively. The AMG and PFC 
accumulated lower amounts (0.05 ± 0.01 and 0.03 ± 0.01 %ID/mm3, respectively). The same as 
in Experiment 1, equal accumulation of the tracer was found on both sides of the CER, 0.01 ± 
0.01 %ID/mm3 (Fig. 10A). Therefore, the PET results from Experiment 1 could be reproduced. 
Statistical analysis of the PET data indicated a significant interaction of the “region” and “brain 
side” factors (F(2.93, 99.44) = 61.00, p < 0.001). The follow up pairwise comparison revealed a 
highly significant difference (p < 0.001) between the ipsilateral and the contralateral sides for all 
the regions but the CER (p > 0.05) (Fig. 10B). 
3.4.3 Rotameter Test  
The average ratios of the ipsilateral vs contralateral rotations in the 3 days group equaled 
0.9 ± 0.1 at the baseline measurement and 1.0 ± 0.7 after the dopaminergic stimulation with 
apomorphine. The corresponding results in the 14 days group were 1.1 ± 0.4 (baseline) and 
1.2 ± 0.5 (test), and in the 28 days group 1.2 ± 0.4 (baseline) and 1.1 ± 0.8 (test). In the control 
group the average baseline “ipsilateral/contralateral rotations” was 1.0 ± 0.2 and the test result 
was 0.8 ± 0.6 (Fig. 11).  
Statistical analysis indicated no significant interaction between the “measurement” and the 
“group” (F(3, 20) = 0.59, p > 0.05), neither a significant main effect of any of the factors 
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(F(1, 20) = 0.05, p > 0.05 for “measurement”, and F(3, 20) = 0.62, p > 0.05 for “group”). 
Therefore, no post-hoc test was performed. 
3.4.4 TH-Staining 
The TH-staining did not show reduced intensity at the injection site as compared to the 
contralateral area in any animal examined in Experiment 3 (Fig. 12). This observation was also 
reflected in the semi-quantification of the results (Fig. 13). In the 3 days group, the staining 
intensity was 94 ± 9 (group mean ± sd) on the injected side and 92 ± 8 on the non-injected side. 
The corresponding values for the 14 days group were 88 ± 8 and 89 ± 9, and for the 28 days 
group 73 ± 10 and 74 ± 9. In the control group, the staining intensity was 98 ± 7 in the injected 
VTA and 97 ± 6 in the contralateral area. 
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4 Discussion 
In the recent years, 52Mn has attracted increased attention in the field of molecular imaging. The 
isotope production and separation methods have been elaborated (Lahiri et al., 2006, Buchholz et 
al., 2013, Buchholz et al., 2015, Graves et al., 2015, Fonslet et al., 2017) and the first preclinical 
application study has been performed (Lewis et al., 2015). In that work, 52Mn was proposed as a 
dual-modality (PET-MRI) tool for long-term tracking of human stem cells transplanted into a rat 
brain. Here, we extend the range of potential applications of 52Mn in the field of neuroimaging by 
showing, for the first time, that neuronal pathways between rat brain regions can be imaged with 
PET. 
We observed that after a unilateral 52Mn administration into the VTA, the mesolimbic and 
nigrostriatal pathways were clearly delineated in PET images 24 h post-injection. These two, as 
well as the mesocortical pathway, are the main projections of the dopaminergic midbrain neurons 
(Björklund and Dunnett, 2007). Despite the fact that the mesocortical tract could not be 
visualized as clearly as the first two pathways, the quantitative PET analysis revealed higher 
concentration of the tracer in the ipsilateral than in the contralateral PFC, indicating that 52Mn 
must have reached that area. Importantly, as can be recognized by comparing Figures 4 and 10, 
a very similar distribution pattern was observed in both PET experiments despite different 
specific activities of the injected solutions. This suggests that the neuronal uptake and transport 
mechanisms were not saturated.  
The analysis also revealed significantly higher tracer amounts in other ipsilateral nuclei known to 
receive neuronal input from the midbrain (NAC, OT, STR, and AMG). The only region for which 
there was no significant difference between the right and left sides was CER, the control region, 
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where we did not expect to detect 52Mn. These results indicate that 52Mn was, in fact, taken up 
and transported by neurons, which had been already demonstrated by many groups for the non-
radioactive Mn2+ (Sloot and Gramsbergen, 1994, Pautler et al., 1998, Saleem et al., 2002, Van der 
Linden et al., 2004, Yang et al., 2011). 
However, based on these data, the type of the neurons by which 52Mn was transported cannot be 
unambiguously defined. Besides the dopaminergic cells, some glutamatergic and GABAergic 
neurons, or neurons containing more than one neurotransmitter, are also present in the VTA 
(Johnson and North, 1992, Omelchenko and Sesack, 2009, Yamaguchi et al., 2011, Hnasko et al., 
2012). Whether 52Mn is preferentially taken up by any of them would require further 
investigations.  
The molecular mechanisms of 52Mn uptake and transport are also not fully explained. It is known 
that microtubules contribute to, although probably are not fully responsible for, the axonal 
transport of 54Mn (Sloot and Gramsbergen, 1994) and the same mechanism would be expected 
for 52Mn. Furthermore, studies utilizing non-radioactive Mn2+ have shown that the transport, as 
well as the uptake, depend on neuronal activity, and that voltage-gated Ca and Na channels are 
involved in these processes (Lin and Koretsky, 1997, Yu et al., 2008, Wang et al., 2015). 
Although it remains to be fully elucidated to what extent and by what molecular mechanisms 
Mn2+ transport occurs in the activity-dependent manner, such findings should apply equally to 
different isotopes of the metal. Performing a simultaneous 52Mn PET – fMRI measurement could 
potentially help to address these issues and verify the possibility of using 52Mn PET as a tool for 
functional neuroimaging.  
An example method of functional neuroimaging with 52Mn PET could rely on the tracer 
administration into the brain via a cannula previously fixed on the skull. Then, the animal would 
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perform a behavioral task while the tracer would be taken up and transported by the involved 
neuronal circuits. This procedure has been already successfully employed in a MEMRI study 
(Inui et al., 2011). It has an advantage of removing the impact of anesthetics on the brain during 
the time when the brain activity is actually recorded, which is the main drawback of most of 
currently performed fMRI studies. A potential difficulty of this approach would be that some 
residual 52Mn might remain in the cannula after withdrawing the injection needle. This could be 
possibly avoided by flushing the guide cannula with a small volume of saline after the injection. 
Moreover, the accuracy with which the 52Mn uptake or transport rates could be measured with 
PET would need to be established. 
One limitation of using 52Mn PET for tracing neuronal pathways is the spatial resolution of PET 
scanners (Mannheim et al., 2012). Currently, in rodents it can be performed at the regional level 
(Fischer et al., 2011, Fischer et al., 2012). Nevertheless, the results of our phantom measurement 
demonstrate that by using an advanced image reconstruction algorithm the dimension of 1.35 mm 
could be resolved. Accordingly, we were able to identify 52Mn in a region as small as the rat SN. 
Moreover, intense work aiming at improving the spatial resolution of PET scanners is taking 
place and simulation results of new designs, as well as first experimental data, show that 
resolution of 0.5-0.6 mm full width at half maximum (FWHM) may be achieved (Park et al., 
2007, Yang et al., 2016). With scanners of the improved spatial resolution, some investigations at 
the sub-regional level may become feasible, at least in rats. 
Alternatively, 52Mn PET could be used for tracing neuronal connections in larger subjects, like 
primates. In fact, the primate central nervous system (CNS) seems to be more sensitive to Mn 
toxicity than the rodent CNS (Aschner et al., 2005). Thus, using 52Mn PET instead of MEMRI 
could be especially beneficial in non-human primate studies. For instance, the method could be 
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applied to evaluate the density or functionality of dopaminergic connections in the monkey PD 
model, as dopaminergic neurons are known to degenerate with the disease progression. This 
cannot be readily performed with MEMRI due to the Mn toxicity whose symptoms themselves 
resemble parkinsonism.  
Potentially, 52Mn PET might be also useful for monitoring the development, progress, or 
treatment response in other animal models of neurodegenerative conditions. MEMRI has been 
already applied to investigate axonal transport in rodent models of aging and Alzheimer’s disease 
(AD) (Minoshima and Cross, 2008). An analogical evaluation, but burdened with a lower risk of 
metal intoxication, could be conducted with 52Mn PET. Further possible applications could 
include tracing olfactory or optical pathways, in which the stereotactic surgery would not be 
necessary. Finally, assessing the integrity of peripheral nerves, for instance after a traumatic 
injury, might be also possible with 52Mn PET. In fact, the potential of MEMRI to examine a 
sciatic nerve injury has been already tested in rats (Matsuda et al., 2010).  
The main advantage of applying 52Mn for PET neuroimaging results from the high sensitivity of 
the technique (Mannheim et al., 2012). It allows using solutions of low concentration and, 
therefore, avoiding toxic effects of the metal. The solutions we used in Experiments 1 and 3 
contained, respectively, 38.3 and 1.1 pmol of Mn2+ per 1 µL, which correspond to the 38.3 µM 
and 1.1 µM concentrations. Importantly, even the former value is lower than the physiological 
concentrations reported for different regions of the rat brain which ranged from 50 to 600 nmol 
per 1 g of tissue (Anderson et al., 2007). Assuming 1 g of tissue corresponds to 1 mL, these 
concentrations can be converted to 50-600 µM. Therefore, we were surprised to observe an 
increased ratio of the ipsilateral vs contralateral rotations in half of the animals tested in 
Experiment 1. 
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In previous studies the turning behavior was caused by unilateral injections of hundreds of nmol 
of Mn2+ (Parenti et al., 1986, Ponzoni et al., 2000, Fernandes et al., 2010). In another study an 
8 nmol dose, but of Mn3+, did cause a significant impairment of spontaneous motor activity and 
conditioned avoidance response two weeks after an intranigral administration (Diaz-Veliz et al., 
2004). Nevertheless, that dose was still over 200 times higher than in our experiments. Moreover, 
toxicity of Mn3+ is related to dopamine oxidation (Diaz-Veliz et al., 2004), an effect that would 
be much weaker for Mn2+ due to its lower reduction potential. Therefore, rather than the metal 
concentration, the radioactivity dose (170 kBq) seemed to be a much more probable cause of the 
observed behavioral impairment.  
Although the behavioral data should be treated carefully due to the relatively small number of 
samples per group and the variation within the VTA and STR groups, they correspond well to the 
results of the TH-staining. The staining indicated a dopaminergic lesion in the VTA group as well 
as in one rat from the STR group in Experiment 1. Even though the difference between the 
injected and the non-injected VTA found with the semi-quantification method should be 
considered only an estimate of the underlying difference in the TH levels, due to the properties of 
the DAB (Loos, 2008), it was significant in the animals treated with the 170 kBq dose. Crucially, 
this effect was completely eliminated after reducing the 52Mn dose to 20 ± 5 kBq in 
Experiment 3. This suggests that the reduction of the radioactivity dose allowed the VTA neurons 
to preserve the ability to synthetize TH. 
Nevertheless, similarly to the behavioral effect, the outcome of the TH-staining in Experiment 1 
was not expected for the applied manganese dose. Specifically, the dopaminergic toxicity of the 
VTA neurons would be expected following an administration of 20-40 nmol of Mn2+ (Li et al., 
2009). In order to better understand whether the ionizing radiation of the tracer, rather than the 
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metal dose, could be responsible for the results, the impact of the radioactivity doses on the DNA 
was investigated in Experiment 2. 
DNA damage is a commonly known effect of ionizing radiation (Olive, 1998). Following a single 
or double strand break (DSB) of DNA, the H2AX protein at the damage site is phosphorylated on 
the 139th serine residue (Rogakou et al., 1998) which initializes the DNA repair process. The 
γH2AX-staining detects the sites where the specific reaction has taken place (Kuo and Yang, 
2008). We found that 90 min after the injection of 150 kBq of 52Mn into the VTA, more γH2AX 
foci were present in the tissue than after application of the 30 kBq dose. The tissues treated with 
the lower dose were difficult to distinguish from the controls. This result strongly suggested that 
the high dose induced a substantial DNA damage.  
In general, DNA breaks can be repaired by the cell, and the foci imaged with the γH2AX-staining 
reflect activation of the DNA repair machinery (Kuo and Yang, 2008). However, the more 
extensive the damage, the more difficult it may be to repair the DNA breaks completely. 
Especially the DSBs are considered the most damaging type of the ionizing radiation-induced 
lesions which, if unrepaired or repaired incorrectly, may be even lethal for the cell (Olive, 1998). 
Therefore, taking into account that the radioactivity dose used in Experiment 1 was even higher 
than 150 kBq, it seems plausible that it induced the DNA damage too complex for the neuronal 
cells to fully deal with. 
In accordance with the above, we did not observe a dopaminergic lesion, neither the increased 
ipsilateral rotating, in any of the rats injected with 20 ± 5 kBq in Experiment 3. It should be 
noticed that the tracer produced for this experiment was obtained by a different separation 
method than for Experiment 1 (as described in the Material and Methods section), which allowed 
improving purity of the solution and its specific activity. Therefore, the metal content in the 
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injection volume was lower in Experiment 3 than in Experiment 1. However, it is not likely that 
this, rather than the reduced radioactivity dose, rescued the dopaminergic neurons. As already 
mentioned, not only was the total manganese concentration of the solution used in Experiment 1 
lower than the physiological concentration, but also none of the rats treated with the decayed 
solution, which must have contained the same amount of metal impurities, exhibited symptoms of 
toxicity. Thus, reduction of the radioactivity dose was most probably of a greater importance.  
It is not completely clear why the amount of foci was also slightly elevated in the contralateral 
VTA in the 150 kBq group. A potential explanation could be that the tracer had been transported 
via neuronal connections, possibly within the ventral tegmental decussation (VTD). In fact, a 
small population of the midbrain neurons, originating in the SN, VTA and VTD, projects also to 
the contralateral striatal regions (Douglas et al., 1987). This explanation could be supported by 
the fact that we observed some 52Mn accumulation in the contralateral NA in Experiment 3 
(Figure 10). The VTAs are located relatively close to each other, and therefore, 90 min could be 
sufficient for the transport. Additionally, some extent of diffusion along the VTD cannot be 
excluded.  
Nevertheless, the aspect of possible cell damage related to the exposure to 52Mn radioactivity 
should be further investigated. It would be particularly interesting to verify whether the affected 
cells may recover after a longer time and whether neurons and glial cells respond similarly to the 
52Mn exposure. Answering these questions would be especially important in case of repeated 
tracer administrations or if the method was to be employed in monkey studies. Due to longer 
distances the tracer would need to travel in a larger brain, its higher dilution along the neuronal 
pathway could be expected. This in turn, may require injecting a higher dose in the first place. 
Future experiments shall address these issues. 
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In summary, we can propose, that the protocol used in Experiment 3, including the tracer 
preparation method and tracer dose, as well as injection and scanning procedures, enables PET 
imaging of rat neuronal pathways without damaging dopaminergic neurons and affecting motor 
control system for up to 4 weeks after a single administration. It also provides a ground for future 
developments and many possible applications. 
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Conclusions 
52Mn was successfully employed for tracing neuronal pathways in rats. A standard stereotactic 
injection procedure allowed delivery of the tracer to the deep brain nucleus from which it was 
transported along known neuronal tracts. Statistical analysis of the PET data confirmed the tracer 
distribution observed in the images. 
Due to the very high sensitivity of PET, pico-molar doses of manganese could be used. However, 
170 kBq of 52Mn resulted in a lesion of dopaminergic neurons and affected motor control system 
4 weeks after injection into the VTA. Moreover, 150 kBq of 52Mn induced DNA breaks in the 
VTA, while the 30 kBq dose did not. Reduction of the radioactivity dose to 20 ± 5 kBq of 52Mn 
eliminated the behavioral and histological noxious effects for up to 4 weeks after administration. 
Crucially, it was still sufficient for PET imaging. 
In summary, the optimized experimental protocol is a promising tool for longitudinal and 
functional imaging of neuronal activity in healthy experimental animals as well as in different 
disease models.  
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6 Figures 
  
Figure 1. Volumes of interest (VOIs) used for PET data analysis. A. VOIs used for analyzing the data of rats 
injected into the ventral tegmental area: prefrontal cortex (blue), striatum (red), nucleus accumbens (turquoise), 
olfactory tubercle (yellow), amygdala (pink), cerebellum (green). B. VOIs used for analyzing the data of rats 
injected into the dorsal striatum: globus pallidus (violet), thalamus (yellow), substantia nigra (red), cerebellum 
(green). Numbers in the upper right corners of images in A and B indicate distance from Bregma in mm. C. 3D 
rendering of VOIs shown in A. D. 3D rendering of the VOIs shown in B. 
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Figure 2. Images of the resolution phantom reconstructed with different algorithms and 
matrices. PET images of the phantom filled with the 52Mn solution are shown in the “coronal” 
(A), “sagittal” (B), and “axial” (C) planes. The smallest rod volumes that could be resolved in 
any of the images were the 1.35 mm diameter rods (pointed by the arrows). They appeared 
clearest in the images reconstructed with the OSEM3D-MAP algorithm and the matrix size of 
256 × 256.  
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Figure 3. 52Mn distribution in PET images (Experiment 1). A. Following injection into the ventral tegmental 
area, 52Mn was transported along the mesolimbic and nigrostriatal pathways. The arrow and arrowhead indicate the 
tracer accumulation in the nucleus accumbens and the striatum, respectively. B. After administration into the 
striatum, 52Mn traced the striatonigral pathway, reaching the ipsilateral substantia nigra (arrow). Its accumulation in 
the thalamus was also prominent (arrowhead).  
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Figure 4. Quantification of the 52Mn distribution in PET images (Experiment 1). A. 24 h after 52Mn injection 
into the right ventral tegmental area (VTA), the highest content of the tracer was found in the ipsilateral nucleus 
accumbens (NAC), striatum (STR), and olfactory tubercle (OT). Lower signal was detected in the amygdala (AMG) 
and prefrontal cortex (PFC). In all the analysed regions, except for the cerebellum (CER), there was higher 52Mn 
accumulation on the ipsilateral than the contralateral side. B. After injection into the right STR the tracer content in 
the adjacent globus pallidus (GP), thalamus (THL), and the ipsilateral substantia nigra (SN) was higher than in the 
respective contralateral regions. This was not the case for the CER. Bars represent mean + SD, n = 4. 
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Figure 5. TH-staining (Experiment 1). The staining revealed dopaminergic lesions in some of the animals 
which expressed an increased ipsilateral/contralateral rotation ratio in the rotameter test. The staining intensity 
was reduced in the ventral tegmental area (VTA) injected with 170 kBq of 52Mn as compared to the contralateral 
VTA. An example is shown in panel A. A similar effect was found in the right substantia nigra, which receives 
projections from the injected striatum, in the STR group. An example is shown in panel B. The TH-staining did 
not show differences between the right and left VTA in the brains of the animals treated with the decayed 
solution. An example is presented in panel C.  
The small rectangles indicate the locations of the sections shown sidewise with the higher magnification. The 
scale bar in panel A represents 20 µm and it applies to all six high magnification images. 
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Figure 6. Semi-quantification of the TH-staining (Experiment 1). The average intensity 
in the VTA region injected with the 170 kBq dose of 52Mn was significantly lower than in 
the non-injected VTA (A). In the intrastriatally injected group, the average intensity was 
measured in the substantia nigra (SN) and there was no significant difference between the 
right and the left side (B). There was also no difference between the VTA treated with the 
decayed solution and the contralateral VTA (C). Bars represent group mean ± sd, n = 4 per 
group, * p < 0.05. 
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Figure 7. γH2AX-staining (Experiment 2). Rats were unilaterally injected with 0 (control), 30, or 150 kBq 
of 52Mn into the ventral tegmental area (VTA) and sacrificed 90 min later. The staining revealed sparse foci 
in the injected region in the control tissues (A) as well as in the tissues injected with 30 kBq of 52Mn (C). 
There were clearly more and larger foci in the tissues injected with the 150 kBq dose (E). Hardly any foci 
were present in the contralateral VTA of the control brains (B) and of the 30 kBq group (D), while some 
were found in the contralateral VTA of the rats injected with the 150 kBq dose (F). The scale bar in A 
represents 10 µm. 
                     Injected VTA          Non-injected VTA 
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Figure 8. γH2AX-staining (Experiment 2). 90 min after 52Mn 
injection, the average ratio of the cells containing at least 3 foci over 
the total number of cells on the injected side was 8 times higher in 
the high dose group than in the low dose and control groups. This 
reflects the qualitative result of the staining (shown in Fig. 7). Also 
in the images of the contralateral VTA, the ratio was higher in the 
150 kBq group compared to the other groups, although the 
difference was smaller. The results of the 30 kBq group hardly 
differed from the control group. Bars represent mean + SD, n = 2. 
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Figure 9. 52Mn distribution in PET images 
(Experiment 3). Rats were injected with app. 
20 kBq of 52Mn into the right ventral tegmental area 
and PET was performed 24 h later. The distribution 
pattern of the tracer was similar to the one observed 
in Experiment 1. The mesolimbic pathway leading 
from the injection site to the nucleus accumbens 
(arrows) as well as the nigrostriatal tract running to 
the dorsal striatum (arrowheads) could be easily 
recognized in the images. 
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Figure 10. Quantification of 52Mn 
distribution in PET images (Experiment 
3). Rats were injected with app. 20 kBq of 
52Mn into the right ventral tegmental area 
(VTA) and PET was performed 24 h later. A. 
The tracer content in the nucleus accumbens 
(NAC), olfactory tubercle (OT), striatum 
(STR), amygdala (AMG), and prefrontal 
cortex (PFC) was measured and the 
distribution pattern was similar to the one 
observed in Experiment 1. B. The data were 
log-transformed for statistical analysis. It 
showed that the measured values were 
significantly higher on the ipsilateral than on 
the contralateral side for all the regions 
except for the cerebellum (CER). Bars 
represent mean ± SD, n = 18, *** p < 0.001. 
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Figure 11. Rotameter test (Experiment 3). 18 rats were injected 
with app. 20 kBq of 52Mn and 6 rats with the buffer solution 
(control) into the right ventral tegmental area. They were tested at 3, 
14, or 28 days post-injection and there was no significant difference 
in the ratio of the ipsilateral vs contralateral rotations between the 
groups. Bars represent mean + SD, n = 6. 
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Figure 12. TH-staining (Experiment 3). The rats were administered with app. 20 kBq of 52Mn into the right 
ventral tegmental area (VTA) and the staining was performed at 3 (panel A), 14 (panel B), or 28 days (panel C) 
post-injection. No sign of a dopaminergic lesion was detected in any of the evaluated slices. There was also no 
difference in the staining intensity between the right and left VTA in the control group (panel D). 
The small rectangles indicate the locations of the sections shown sidewise with the higher magnification. The 
scale bar in panel A represents 20 µm and it applies to all the high magnification images. 
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Figure 13. Semi-quantification of the TH-staining 
(Experiment 3). The signal intensity in the VTA injected 
with the 20 kBq dose of 52Mn was statistically compared to 
the signal intensity in the contralateral VTA using the paired 
t-test. This was done separately for each experimental group: 
the 3 days group (A), the 14 days group (B), the 28 days 
group (C) and the 28 days – control group (D). There was no 
significant difference in any of the groups. Bars represent 
mean ± sd, n = 3 per group. 
 
